0001651281-15-000002.txt : 20150819 0001651281-15-000002.hdr.sgml : 20150819 20150819140741 ACCESSION NUMBER: 0001651281-15-000002 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150817 FILED AS OF DATE: 20150819 DATE AS OF CHANGE: 20150819 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACUCELA INC. CENTRAL INDEX KEY: 0001400482 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 020592619 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1301 SECOND AVE. STREET 2: SUITE 4200 CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: 206-805-8300 MAIL ADDRESS: STREET 1: 1301 SECOND AVE. STREET 2: SUITE 4200 CITY: SEATTLE STATE: WA ZIP: 98101 FORMER COMPANY: FORMER CONFORMED NAME: Acucela Inc DATE OF NAME CHANGE: 20070523 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHEIBLER LUKAS CENTRAL INDEX KEY: 0001651281 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55133 FILM NUMBER: 151063659 MAIL ADDRESS: STREET 1: 1301 SECOND AVENUE, SUITE 4200 CITY: SEATTLE STATE: WA ZIP: 98101 3 1 wf-form3_144000765162895.xml FORM 3 X0206 3 2015-08-17 0 0001400482 ACUCELA INC. M?????? 0001651281 SCHEIBLER LUKAS C/O ACUCELA INC. 1301 SECOND AVE., SUITE 4200 SEATTLE WA 98101 0 1 0 0 EVP of Translational Medicine Common Stock 0 D The issuer's common stock trades on the Tokyo Stock Exchange under the symbol referenced in the issuer's registration statement on Form S-1 (File No. 333-192000). No securities beneficially held. /s/ John E. Gebhart as attorney-in-fact for Lukas Scheibler 2015-08-19